Public Release: 

EuroPCR 2018, the world's leading course in interventional cardiovascular medicine

EuroPCR 2018 will be taking place in Paris, France, from May 22-25, 2018


With an expected attendance of 10,000 interventional cardiologists, scientists, nurses, allied professionals and industry, EuroPCR 2018 will be welcoming the world of minimally invasive endovascular medicine to the Palais des Congrès in Paris, France, 22-25 May. In a tradition that spans several decades, this dynamic and constantly evolving Course brings together clinicians, innovators, researchers, industry and health professionals to share their experience for the present and their ideas for the future. Presentations and discussions will cover the latest developments, research and best practice in the treatment of coronary and valvular heart disease, peripheral interventions and stroke.

Marked by a commitment to education, EuroPCR 2018 ensures the highest academic and clinical standard in a Course created "By and For" the participants and is one of the approved continuing medical education (CME) meetings under the new MedTech Code of Ethical Business Practice governing industry/doctor relations permitting sponsorship of healthcare professionals by MedTech members.

With a renewed programme at the cutting edge of minimally invasive techniques in endovascular medicine, this year's Course will feature many "hands-on" sessions with valuable "take-home" practice-changing information.

Live cases will be broadcast from 9 international centres including the Mohammed Bin Khalifa Cardiac Centre, Royal Medical Services, Bahrain Defence Force, from West Riffa, Bahrain; the Clinique Pasteur in Toulouse, France; John Radcliffe Hospital, Oxford University Hospital, Oxford, United Kingdom; Cardiovascular Centre Frankfurt, Frankfurt, Germany; Fu Wai Hospital, National Centre for Cardiovascular Diseases, Beijing, China; the Swiss Cardiovascular Centre, Bern University Hospital in Bern, Switzerland; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy; Hospital Universitario Clínico San Carlos, Madrid, Spain; and the Institut Cardiovasculaire Paris Sud, Massy, France.

Focus on drugs and devices synergy

New to EuroPCR in 2018, the focus on pharmacological care in the context of interventional medicine is critical for understanding and better use of the vast resources available today. There will be four case-based sessions led by leading specialists on such topics as DAPT, optimal antithrombotic cocktails after TAVI, switching antiplatelet agents and managing triple therapy. These sessions will conclude with a practical "PCR clinical algorithm", not a formal guideline, but rather a way of thinking and approaching these complex scenarios from initial selection of a drug to its interaction with the selected device to the specific clinical situation itself.

Late Breaking Trials - Critical issues in interventional cardiology

The latest data coming out of internationally recognised trials that are making a difference in current and future practice will be released during EuroPCR 2018.


  • ORBITA: a physiology-stratified analysis of the impact of FFR and iFR on the efficacy of coronary angioplasty in stable coronary artery disease (presented in the main arena Tuesday 22 May at 12:20 by Dr R. Al-Lamee)
  • FAME 2, DANAMI-3-PRIMULTI, and COMPARE-ACUTE: accumulating long-term data on the comparative value of physiological guidance for stent targeting will be discussed, with a focus on potential impact on cardiac death and myocardial infarction (presented in the main arena Tuesday 22 May at 13:05)
  • SYNTAX III Revolution: non-invasive Heart Team assessment of multivessel coronary disease managed either by coronary CT angiography or by invasive angiography (presented in the main arena Tuesday 22 May at 13:30 by Prof. P.W. Serruys)

There will also be key statements on:

  • PCR statement on renal denervation-based therapies for hypertension by Prof. F. Mahfoud
  • PCR statement on PCI for stable Coronary Artery Disease by Prof. M. Haude

Simulations and "hands-on" training sessions are of critical value in sharing experience. EuroPCR 2018 will feature:

  • TEACH @EuroPCR
    TEACH or Training and Education in Advanced Cardiovascular Haemodynamics are two sessions offering the fundamentals of cardiovascular physiology and haemodynamics in relation to mechanical circulatory support. Devices, drugs ... patient selection, all will be touched on in these sessions (in collaboration with TEACH-CRF).
  • Workshops on bail-out techniques
    A joint educational project between PCR and Terumo Learning EDGE™ offers participants a shared and collaborative learning experience involving device-related complications. Eight workshops will permit participants to understand, better manage and offer their patients the best outcome.
  • Management of complications live!
    Improving teamwork, from communications to coordination of the treatment, these sessions will offer a simulation of what's needed to face emergency situations effectively - together.

PCR Peripheral for Beginners

Are you an interventional cardiologist interested in beginning your own peripheral treatment programme? Join the travelling PCR Peripheral Course, which has successfully taken place in different meetings throughout Europe as it joins with EuroPCR 2018 to offer its special blend of clinical experience and knowledge in sessions dedicated here to simple aorto-iliac and superficial femoral artery popliteal interventions.

PCR Clinical Research

Devoted to optimising clinical research by fully understanding "the fundamental link between clinical research and best clinical care, with the ultimate goal of addressing the needs of the patient". These sessions are aimed at physicians, research fellows, research nurses and coordinators, industry partners, CRO representatives and regulators - anyone who is committed to becoming "more proficient actors" either as individuals or in a team to improve their understanding of research from critical thinking, to participating in a study, to running a study themselves.

Education can also be enjoyable, and EuroPCR emphasises this with such sessions as "PCR's Got Talent" where the young interventionalists compete to have their scientific abstract chosen by participants as the "best in show", or "An image is worth a 1,000 words". A modern guessing game that underlines the complexity - and crucial importance - of interpreting images today.

  • What do you see?
  • Which diagnostic elements do you recognise?
  • How would you treat?

Dates to remember:

  • EuroPCR: 22-25 May 2018
  • PCR Innovators Day: 21 May 2018
    A rare moment to network with all the players in the field - whether inventors, doctors, industry or investors - an essential building block for the continued evolution of our practice.
  • EAPCI Fellows Course: 21-22 May 2018
    Starting a day before the EuroPCR Course, designed "By & For" young interventionalists."
  • Stent Save a Life! Forum: 21 May 2018
    The next step in the success story that was the Stent for Life programme, Stent Save a Life! allows this life-changing initiative to expand globally.


For any press-related inquiries, please contact EuroPCR Press Coordinator, Isabelle Uzielli:

Register and attend EuroPCR 2018 as a journalist

Press registration for EuroPCR is open to accredited journalists, free of charge. Journalists must hold a valid press card and/or provide a letter of assignment from a recognised publication. To register as press go to

EuroPCR press releases

EuroPCR press releases can be found at

Attend press briefings

For the press briefing schedule check

EuroPCR abstracts

Abstracts are available online at



What is EuroPCR?

EuroPCR is the world-leading Course in interventional cardiovascular medicine, and the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), a registered branch of the European Society of Cardiology.

In addition to this flagship course in Paris, PCR offers a large range of many other educational meetings and resources for the continuing education of the interventional cardiovascular community. These include major annual Courses across the globe, E-Learning with high-profile PCR Webinars, Courses specifically dedicated to valvular heart disease, tailor-made PCR Seminars on specific topics, online resources and medical publications such as EuroIntervention, the official journal of the EAPCI.

For more information, please visit: and follow us on Twitter using the hashtag #EuroPCR

Gateways to all PCR activities are available on

For further information, please contact: Célia Vilà:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.